About 300 million people worldwide live with a rare disease. While these conditions are individually uncommon, the challenges they bring are shared by millions. One such condition is Peeling Skin Syndrome (PSS), a group of rare genetic disorders that cause the skin to peel continuously and tear easily. The hallmark symptom is persistent peeling of the skin.
The stock we are bringing to your attention today is that of Quoin Pharmaceuticals Ltd. (QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Prabha Kurup
For comments and feedback: contact editorial@rttnews.com